YPL035C Antibody

Basic Research Questions

• What is YPL035C and how do researchers validate antibodies against this yeast protein?

YPL035C is a systematic name for a Saccharomyces cerevisiae gene located on chromosome XVI. Antibodies targeting this protein require rigorous validation to ensure specificity and reproducibility.

A recommended validation protocol includes:

• Using CRISPR/Cas9 to generate knockout cell lines that lack the YPL035C gene

• Performing immunoblot comparisons between parental and knockout cells

• Testing the antibody in additional applications such as immunoprecipitation and immunofluorescence

• Confirming specificity across different cell types expressing varying levels of the target

This systematic approach mirrors validated protocols for antibody characterization described in immunology literature. For example, one study found that "implementation of an antibody characterization procedure addresses the reproducibility crisis resulting from the use of non-specific antibodies" .

• What are the optimal methods for using YPL035C antibodies in immunoblotting experiments?

For optimal immunoblotting with YPL035C antibodies:

• Use gradient polyacrylamide gels (5-16%) to allow proper separation of proteins

• Transfer to nitrocellulose membranes and verify transfer with Ponceau staining

• Block with 5% milk in TBS with 0.1% Tween 20 (TBST)

• Incubate primary antibodies overnight at 4°C in 5% BSA in TBST

• Use peroxidase-conjugated secondary antibodies at 1:10,000 dilution

• For quantitative immunoblots, use total protein stains like REVERT for normalization

Research has shown that "large 5–16% gradient polyacrylamide gels and nitrocellulose membranes" provide optimal resolution for detecting specific protein bands .

• How should YPL035C antibodies be assessed for specific immunoprecipitation applications?

For evaluating YPL035C antibodies in immunoprecipitation:

• Prepare cell lysates in HEPES buffer (pH 7.4) supplemented with protease inhibitors

• Pre-clear lysates with empty protein G Sepharose beads (30 min, 4°C)

• Incubate pre-cleared lysates with antibody-coupled beads (4-18 hours, 4°C)

• Collect unbound fractions and wash beads with lysis buffer

• Analyze bound proteins by SDS-PAGE and immunoblot or mass spectrometry

• Always include knockout controls to identify non-specific binding

Scientific literature shows that "Analysis by mass spectrometry revealed hundreds of proteins in the immunoprecipitates from parental cells. While the vast majority of these proteins were also detected in immunoprecipitates from the KO cells, indicating that they are not relevant binding proteins" , highlighting the critical importance of proper controls.

• What are recommended protocols for immunofluorescence using YPL035C antibodies?

For immunofluorescence with YPL035C antibodies:

• Grow cells on glass coverslips for 24-48 hours

• Fix cells with either 4% PFA for 10 minutes or cold methanol (-20°C) for 10 minutes

• Block and permeabilize in TBS containing 5% BSA and 0.3% Triton X-100 for 1 hour

• Incubate with primary antibody at 2 μg/ml concentration overnight at 4°C

• Wash 3 times (10 minutes each) with blocking buffer

• Incubate with fluorophore-conjugated secondary antibodies (1:1000) for 2 hours

• Mount using appropriate mounting media

For validation, create mosaic cultures of wild-type and knockout cells expressing different fluorescent markers to easily identify true versus false positive staining patterns .

Advanced Research Questions

• How can I develop and screen yeast display libraries for generating antibodies against YPL035C?

Yeast surface display offers significant advantages for antibody development against yeast proteins like YPL035C:

• Library Construction:

  • Create antibody fragment libraries through CPEC assembly or similar methods

  • Fuse antibody genes to Aga2p for display on the yeast cell surface

  • Typical library sizes should exceed 10^7 unique clones for adequate diversity

• Selection Process:

  • Label library with biotinylated target antigens and anti-display tag antibodies

  • Perform multiple rounds of FACS to enrich high-affinity binders

  • Sort for cells showing both antigen binding and display marker positivity

• Screening Metrics:

  • Enrich for binders with decreased antigen dissociation rates

  • Apply quantitative flow cytometric analysis for kinetic discrimination

Research demonstrates that "Display on the yeast cell wall is well suited for engineering mammalian cell-surface and secreted proteins... that require endoplasmic reticulum-specific post-translational processing for efficient folding and activity" . This approach has successfully "been used for the selection of scFv antibody fragments with threefold decreased antigen dissociation rate from a randomly mutated library" .

• What methodologies can determine the epitope specificity of anti-YPL035C antibodies?

Advanced epitope mapping techniques include:

• CryoEM Polyclonal Epitope Mapping (cryoEMPEM):

  • Complex YPL035C with polyclonal antibodies

  • Obtain high-resolution (3-4Å) cryoEM maps of immune complexes

  • Use focused classification to improve map quality

  • Combine with NGS of B-cell repertoires to identify antibody sequences

• Mutagenesis-Based Mapping:

  • Generate alanine-scanning or deletion mutants of YPL035C

  • Test antibody binding to mutant proteins via immunoblot or ELISA

  • Identify critical residues that abolish antibody recognition

• Peptide Array Analysis:

  • Screen antibodies against tiled peptide arrays spanning YPL035C

  • Identify linear epitopes or mimotopes recognized by the antibody

Research confirms that "application to major ALS disease gene C9ORF72 identified high-quality antibodies revealing C9ORF72 localization to phagosomes/lysosomes" using similar epitope-mapping techniques.

• How can I optimize antibody-cell conjugation techniques for YPL035C-expressing yeast cells?

For antibody-cell conjugation (ACC) with yeast cells expressing YPL035C:

Research indicates that "antibody-cell conjugation can be performed simply and efficiently by chemoenzymatic method, which provides a new idea for the research and development of cell therapy and has a broad potential application value" .

• What techniques can I use to overcome cross-reactivity issues with YPL035C antibodies?

To address and resolve cross-reactivity challenges:

• Absorption Techniques:

  • Pre-incubate antibodies with lysates from YPL035C knockout yeast

  • Remove cross-reactive antibodies through multiple absorption cycles

  • Validate specificity by comparing signal between wild-type and knockout samples

• Advanced Validation:

  • Use PaxDB (https://pax-db.org/) to identify yeast strains expressing varying levels of YPL035C

  • Create a panel of cell lines with different expression profiles

  • Perform quantitative immunoblots to correlate signal with known expression levels

  • "Use the selected edited line to screen antibodies for specificity by immunoprecipitation and immunofluorescence"

• Sequential Epitope Mapping:

  • Identify cross-reactive epitopes through mass spectrometry of immunoprecipitated proteins

  • Design strategies to specifically deplete antibodies recognizing these regions

Studies emphasize that "based on this experience we recommend that once immunoblot screens identify a specific antibody for a target of interest, the next step should involve screening panels of cell lines with that antibody to find those with the highest expression levels" .

• How can flow cytometry be optimized for detecting YPL035C antibodies in research applications?

Optimizing flow cytometry for YPL035C antibody applications:

• Antibody Titration:

  • Perform systematic titration series to determine optimal antibody concentration

  • Analyze signal-to-noise ratio and staining index at each concentration

  • "The performance criteria of antibody conjugates are application dependent and should be validated as such"

• Panel Design:

  • Select compatible fluorophores with minimal spectral overlap

  • Include positive and negative controls in all panels

  • Use fluorescence minus one (FMO) controls to set proper gates

• Sample Preparation:

  • Optimize fixation and permeabilization protocols specifically for yeast cells

  • Test multiple fixation methods (PFA vs. methanol) to determine which best preserves epitopes

  • Ensure proper blocking to minimize non-specific binding

Research indicates that "relatively low level of signal intensity reproducibility is needed for discretely expressed antigens... a much higher intensity reproducibility is needed for variable quantitative measurements" .

• What alternative methods exist for generating antibodies against YPL035C without using animal hosts?

Animal-free approaches for generating YPL035C antibodies:

• Yeast-Based Systems:

  • "Detouring around a major research roadblock, researchers have found a new way to create valuable antibodies without needing llamas"

  • Create libraries of 500+ million camelid antibodies in yeast cells

  • Each yeast cell displays a slightly different nanobody on its surface

  • Label YPL035C with fluorescent molecules and use FACS to identify binding partners

  • Process takes "three to six weeks instead of three to six months"

• Yeast Mating for Library Diversity:

  • "We developed an optimized method of yeast mating for generating a large, combinatorial antibody fragment library and heterodimeric protein library"

  • Use cellular fusion between two haploid cells carrying different libraries

  • Enables increased diversity in screening target-specific antibodies

• Advantages of In Vitro Methods:

  • No animal facilities required

  • "While the animals are not harmed, vaccinating them to generate the desired antibodies is expensive, takes as long as six months per attempt and often doesn't work"

  • More consistent results and higher success rates

These approaches align with the 3Rs principles (Replacement, Reduction, Refinement) in research animal use while potentially offering superior results.

• How can I implement an antibody-validation pipeline for YPL035C research?

A structured validation pipeline includes:

• Expression Analysis:

  • Use PaxDB to identify cell lines with high YPL035C expression

  • Select lines amenable to genetic modification and routine culture

• Genetic Controls:

  • Generate CRISPR/Cas9 knockout lines

  • Create paired wild-type/knockout controls for all validation steps

• Multi-Method Validation:

  • Primary screen: Immunoblot comparing parental and knockout cells

  • Secondary screen: Quantitative immunoblot across cell line panels

  • Tertiary screen: Immunoprecipitation and immunofluorescence validation

  • Advanced applications: Immunohistochemistry if applicable

• Documentation:

  • Create comprehensive validation documents for each antibody

  • Include specificity data, optimal conditions, and limitations

This approach is supported by research stating: "With high-quality antibodies new biology can emerge. The technologies employed are simple, easily applicable to any cell biological laboratory, and scalable" . Implementation of such protocols "can serve as a template for granting agencies and journals as a mechanism to ensure enhanced reproducibility" .

Methodological Considerations

• How should I analyze molecular interactions between YPL035C antibodies and their targets?

To quantitatively assess YPL035C antibody interactions:

• Biolayer Interferometry (BLI):

  • Immobilize purified YPL035C on biosensors

  • Measure real-time binding kinetics (kon and koff)

  • Calculate dissociation constants (Kd) for affinity determination

  • Research shows "dissociation constants (Kd) from BLI were 890 nM and 180 nM" for similar yeast-protein antibodies

• Sandwich ELISA:

  • Capture YPL035C using a validated antibody

  • Detect with test antibody followed by enzyme-conjugated secondary

  • Generate dose-response curves and calculate EC50 values

  • "EC50 values from ELISA experiments with IgGs were 1.93 µg/ml and 2.64 µg/ml" for comparable antibodies

• Advanced Structural Analysis:

  • Use negative-stain electron microscopy (nsEM) for initial characterization

  • Progress to high-resolution cryoEM for detailed epitope mapping

  • "The final map resolutions for complexes were 3.3 Å and 3.5 Å, respectively" in comparable studies

These methods provide complementary data about binding specificity, affinity, and structural interactions.